The E.Z.N.A.® Micro RNA Kit combines the reversible binding properties of the HiBind® matrix, a new silica-based material, with the highly efficient lysis ability of RNA-Solv® to extract micro and large (200 nt) RNA from a wide variety of starting materials. Micro and large RNA are separated to allow for quantification into downstream applications.
The system uses RNA-Solv® to efficiently lyse cells and protect RNA from degradation. Following a chloroform separation step, RNA is applied to a HiBind® RNA column where large RNA binds. The flow-through is retained and applied to a HiBind® Micro...
The E.Z.N.A.® Micro RNA Kit combines the reversible binding properties of the HiBind® matrix, a new silica-based material, with the highly efficient lysis ability of RNA-Solv® to extract micro and large (200 nt) RNA from a wide variety of starting materials. Micro and large RNA are separated to allow for quantification into downstream applications.
The system uses RNA-Solv® to efficiently lyse cells and protect RNA from degradation. Following a chloroform separation step, RNA is applied to a HiBind® RNA column where large RNA binds. The flow-through is retained and applied to a HiBind® Micro...
Shipping & Handling
Shipped In
Ambient
Safety & Storage
Storage Temperature
15-25°C, See Components for Storage Conditions
Safety Statement
For Research Use Only. Not for use in diagnostic procedures.
Regulatory & Compliance
Specifications
CLASS
RNA
SUBCLASS
miRNA Isolation
COUNTRY OF ORIGIN
United States
*USAGE / SAFETY STATEMENT
For Research Use Only. Not for use in diagnostic procedures.
QUALITY CERTIFICATION / COMPLIANCE
Omega Bio-tek is ISO 9001:2015 and ISO 13485:2016 certified by NSF-ISR.
Questions & Answers (0)
Citations (0)
Shipping & Handling
Shipped In
Ambient
Safety & Storage
Storage Temperature
15-25°C, See Components for Storage Conditions
Safety Statement
For Research Use Only. Not for use in diagnostic procedures.
Regulatory & Compliance
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.